Shijie Cai
Principal Investigator
- Member of Steering Committee of Global Cholangiocarcinoma Alliance
- Doctor of Philosophy (PhD) - Gene Therapy, University of Cambridge
- Master of Philosophy (MPhil) - Paediatric Viral Respiratory Infection, University of Liverpool
- Clinical Research Fellow - Paediatric Infectious Diseases, Alder-Hey Children Hospital, University of Liverpool
- Doctor of Medicine - Tongji Medical University, China
Integrative omics analysis and target development for various cancer types
Our research interests lie in studying the molecular mechanisms of the tumour microenvironment and target development. We focus on the impact of metabolism and epigenetic regulation on crosstalk between stromal cells and tumour cells. The ongoing investigated tumours include colorectal cancer, breast cancer and cholangiocarcinoma.
GROUP MEMBERS:
Galina Boskh - DPhil student
Gemma Owen - DPhil student
Tiago Felismino - MSc student
Post-doctoral Research Assistant position open for application
Recent publications
-
Data from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
Other
Wang Z. et al, (2024)
-
Supplementary Data from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
Other
Wang Z. et al, (2024)
-
Supplementary Data from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
Other
Wang Z. et al, (2024)
-
Supplementary Figures from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
Other
Wang Z. et al, (2024)
-
Supplementary Figures from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
Other
Wang Z. et al, (2024)